These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 2813496
1. Effects of 5-lipoxygenase inhibition on cardiac anaphylaxis in isolated guinea pig hearts. Jolly SR, Travis J, Van Inwegen RG. Pharmacology; 1989; 38(6):352-62. PubMed ID: 2813496 [Abstract] [Full Text] [Related]
2. The inhibition of 5-lipoxygenase by RG 6866. Carnathan GW, Sweeney DM, Travis JJ, Gordon RJ, Sutherland CA, Jariwala N, Clearfield M, O'Rourke S, Huang FC, Van Inwegen RG. Agents Actions; 1989 Nov; 28(3-4):204-11. PubMed ID: 2596372 [Abstract] [Full Text] [Related]
3. Modulation of coronary flow rate and cardiac contractility by the divalent cation ionophore A23187 and inhibitors of the cyclooxygenase and 5-lipoxygenase pathways: development of heterogeneous patterns of myocardial ischemia. Björnsson OG, Kobayashi K, Williamson JR. Naunyn Schmiedebergs Arch Pharmacol; 1988 Feb; 337(2):191-202. PubMed ID: 3130582 [Abstract] [Full Text] [Related]
4. Effects of exogenous prostaglandins on the release of leukotriene C4-like immunoreactivity and on coronary flow in indomethacin-treated anaphylactic guinea-pig hearts. Aehringhaus U, Dembinska-Kiéc A, Peskar BA. Naunyn Schmiedebergs Arch Pharmacol; 1984 Jul; 326(4):368-74. PubMed ID: 6384796 [Abstract] [Full Text] [Related]
5. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on bronchial anaphylaxis in anaesthetized guinea-pigs. Payne AN, Garland LG, Lees IW, Salmon JA. Br J Pharmacol; 1988 Jun; 94(2):540-6. PubMed ID: 3395791 [Abstract] [Full Text] [Related]
12. Effects of a 5-lipoxygenase inhibitor, REV-5901, on leukotriene and histamine release from human lung tissue in-vitro. Tennant CM, Seale JP, Temple DM. J Pharm Pharmacol; 1987 Apr; 39(4):309-11. PubMed ID: 2438401 [Abstract] [Full Text] [Related]
13. Antagonism of leukotriene receptors and administration of a 5-lipoxygenase inhibitor do not affect hypoxic vasoconstriction. Thomas HM, Sourour MS, Lopez D, Foster SH. Lung; 1989 Apr; 167(3):187-98. PubMed ID: 2567790 [Abstract] [Full Text] [Related]
15. 2,3,5-Trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone (AA861), a selective inhibitor of the 5-lipoxygenase reaction and the biosynthesis of slow-reacting substance of anaphylaxis. Yoshimoto T, Yokoyama C, Ochi K, Yamamoto S, Maki Y, Ashida Y, Terao S, Shiraishi M. Biochim Biophys Acta; 1982 Nov 12; 713(2):470-3. PubMed ID: 6817808 [Abstract] [Full Text] [Related]
16. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Ku EC, Raychaudhuri A, Ghai G, Kimble EF, Lee WH, Colombo C, Dotson R, Oglesby TD, Wasley JW. Biochim Biophys Acta; 1988 Apr 15; 959(3):332-42. PubMed ID: 2833314 [Abstract] [Full Text] [Related]
19. Interaction between leukotriene D4 and adenosine or iloprost in the isolated working guinea-pig heart: prevention of the leukotriene D4 effect. Björnsson OG, Kobayashi K, Williamson JR. Eur J Clin Invest; 1987 Apr 15; 17(2):146-55. PubMed ID: 2438141 [Abstract] [Full Text] [Related]
20. N-[(arylmethoxy)phenyl] and N-[(arylmethoxy)naphthyl] sulfonamides: potent orally active leukotriene D4 antagonists of novel structure. Musser JH, Kreft AF, Bender RH, Kubrak DM, Carlson RP, Chang J, Hand JM. J Med Chem; 1989 Jun 15; 32(6):1176-83. PubMed ID: 2498516 [Abstract] [Full Text] [Related] Page: [Next] [New Search]